Nature Immunology, Published online: 12 April 2024; doi:10.1038/s41590-024-01817-w
Here, the authors describe biallelic loss-of-function variants in human SHARPIN in individuals with autoinflammation and immunodeficiency, termed sharpenia. They also successfully treat one of these individuals with TNF inhibitors.